UK Markets closed

Zynerba Pharmaceuticals, Inc. (0M40.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.9830-0.1870 (-15.98%)
At close: 05:20PM BST
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 2.11
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.9830
52-week low 30.9830
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 517.62M
Implied shares outstanding 6N/A
Float 840.16M
% held by insiders 13.94%
% held by institutions 130.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.61%
Return on equity (ttm)-56.94%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -36.52M
Net income avi to common (ttm)-37.31M
Diluted EPS (ttm)-1.0430
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)67.81M
Total cash per share (mrq)1.63
Total debt (mrq)562.76k
Total debt/equity (mrq)0.79
Current ratio (mrq)8.10
Book value per share (mrq)1.96

Cash flow statement

Operating cash flow (ttm)-33.46M
Levered free cash flow (ttm)-19.28M